A major advance in cancer research is emerging with the use of VHH fragments to reactivate dysfunctional p53. This vital cancer protector protein is frequently disabled in many kinds of cancer, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research